Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 103 are a BUY (87.29%), 15 are a HOLD (12.71%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 17.33% that have a potential upside of 50.11% achieved within 52 days.
Emily Bodnar’s has documented 227 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NKTX, Nkarta at 15-Aug-2024.
Analyst best performing recommendations are on NVCR (NOVOCURE LTD).
The best stock recommendation documented was for VTYX (VENTYX BIOSCIENCES) at 9/1/2022. The price target of $36 was fulfilled within 11 days with a profit of $14.01 (63.71%) receiving and performance score of 57.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
48
$0.45 (0.95%)
48
1 years 22 days ago
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
56
1 years 2 months 5 days ago
0/1 (0%)
$27.35 (95.46%)
Hold
48
$0.45 (0.95%)
68
1 years 2 months 11 days ago
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
48
$0.45 (0.95%)
38
1 years 2 months 11 days ago
1/2 (50%)
$1.56 (3.36%)
27
Hold
48
$0.45 (0.95%)
71
1 years 2 months 11 days ago
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?